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Abstract
Background: Sub-Saharan Africa suffers from a high burden of undernutrition, affecting 23.2% of its population,
and in 2015 constituted 69% of the estimated people living with Human Immunodeficiency Virus (HIV) globally.
Zimbabwe, in Southern African has a HIV prevalence of 14.7%, but malnutrition (under- and over-nutrition) in
this population has not been characterized. A nationally representative survey was therefore conducted to determine
malnutrition prevalence and associated factors among HIV-positive adults (≥15 years) enrolled at antiretroviral therapy
(ART) clinics in Zimbabwe.
Methods: Height and weight measurements were taken for all enrolled participants who had attended their
scheduled clinic review visits. Malnutrition was determined using body mass index (BMI) calculations and
classified as undernutrition (<18.5 kg/m2), normal (18.5–24.9 kg/m2) or over-nutrition (≥25 kg/m2). Multivariate-adjusted
odds ratios (aOR) were used to assess factors associated with undernutrition and over-nutrition.
Results: Of 1,242 HIV-positive adults interviewed, 849 (69%) were female and median age was 41 years (IQR, 34–49).
The majority (93%) were on ART with a median treatment duration of 3 years (IQR, 1.1–4.3) and 581 (56%) had advanced
HIV disease and a median CD4 cell count of 348 cells/uL (IQR, 174–510) at their last scheduled visit. There were 776 (63.6%)
who had a normal BMI, 122 (10%) who had under-nutrition (1.4%-severe; 1.5%-moderate; 7.1%-mild) and 322 (26.4%) who
had over-nutrition (18.4%-overweight; 8%-obesity). Females and those of older age (35-44 years and ≥45 years)
versus 15–24 years were less likely to have undernutrition. Those reporting difficulty in accessing food in the
past month [aOR = 1.67 (95%CI, 1.10–2.55)] and who had advanced HIV disease [aOR = 2.25 (95% CI, 1.34–3.77)]
were more likely to have undernutrition. Being overweight or obese was more likely in females [aOR = 3.86
(95% CI, 2.72–5.48)], in those age ≥45 years [aOR = 2.24 (95% CI,1.01–5.04)], those with higher wealth quintile
and those with CD4 > 350 cells/mL[aOR = 4.85 (95% CI, 1.03–22.77)].
Conclusion: Zimbabwe faces two types of nutritional disorders; undernutrition and overweight / obesity, in its
HIV-infected population, both of which are associated with increased morbidity and mortality. This may reflect a
shift in the pattern of HIV/AIDS from being a highly fatal infectious disease to a chronic manageable condition.
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Background
There is increasing interest globally about malnutrition
which directly affects one in three people living in the
world [1], and refers to both undernutrition and over-
nutrition [2]. Malnutrition and dietary factors are im-
portant risk factors for the global burden of diseases
such as diabetes [3], cardiovascular disease [4], and
tuberculosis [5, 6]. According to the 2016 Global Nutri-
tion report, the economic consequences of malnutrition
represent losses of 11% of Gross Domestic Product
(GDP) every year in Africa and Asia, whereas preventing
malnutrition delivers US$16 in returns on investment
for every US$1 spent [1].
Sub-Saharan Africa in particular has the highest preva-
lence estimates of undernourishment in the world, with
23.2% of its population affected [7]. Likewise, the region
has the highest burden of Human Immunodeficiency
Virus (HIV) infection, constituting 69% of the estimated
36.7 million people living with HIV globally in 2015 [8].
HIV infection results in functionally defective metabolic
ability at the individual level to absorb, store and utilize
nutrients thus resulting in nutrient deficiencies, com-
promised immunity and increased risk of acquiring
infectious diseases [9]. Insufficient food intake, together
or with malabsorption, result in further progression of
HIV-disease [10], and the subsequent weight loss and
severe malnutrition that ensue are significant predictors
of Acquired Immune Deficiency Syndrome (AIDS)
related morbidity and mortality [11]. Despite the high
global burden of HIV/AIDS, between 2010 and 2015
there has been more than a two-fold increase in the
number of HIV-positive people receiving antiretroviral
therapy (ART), which reached 10.3 million in eastern
and southern Africa, the world’s most affected regions.
The scale up of ART has resulted in AIDS-related
deaths in the region decreasing by 36% since 2010.
While this is good news, there are certain factors
associated with poor outcomes. For example, in sub-
Saharan Africa, malnutrition in the form of low body
mass index (BMI) is common at ART initiation
ranging from 10% to 33% [12–15] and this is associ-
ated with poor treatment outcomes and increased
mortality [13, 16].
Zimbabwe is one of the sub Saharan countries worst
affected by the HIV epidemic with an HIV prevalence of
14.7% (14.66–14.71%) among adults aged 15–49 years
according to the 2015 national HIV estimates [17]. This
translates to an estimated 1.4 million people aged 15 years
and older living with HIV, although as of December 2015,
only 788,000 (56%) were enrolled on ART (source =
National ART Programme). Zimbabwe’s gross domestic
product per capita in 2015 was US$924,10 compared
to US$1,588.50 for the whole sub-Saharan Africa region
[18]. Currently there is inadequate information on
malnutrition prevalence among people living with HIV
(PLHIV) in Zimbabwe and anecdotal evidence also sug-
gests that nutritional assessment, care and support for
PLHIV are weak. In line with Ministry of Health and Child
Care in Zimbabwe (MoHCC) priorities, nutrition in
people living HIV is a priority under the focal area of care,
treatment and mitigation in the Zimbabwe National HIV/
AIDS Strategic Plan (ZNASP) II 2011-2015 document.
The MoHCC therefore commissioned a study to better
understand the interactions between HIV and nutrition in
the country. The study was aimed at determining i) preva-
lence of malnutrition and ii) factors associated with both
undernutrition and over-nutrition among PLHIV enrolled
at ART clinics in Zimbabwe.
Methods
Study design
A nationally representative analytical cross-sectional
study design was used.
Study participants and sampling
A list of 792 health facilities providing HIV treatment
and care services inclusive of ART as of 31st December
2012 was used as the sampling frame for this study. In
order to keep the study logistically and financially
feasible, sites which had supported less than 400
HIV-positive patients through HIV treatment and care
services by 31st December 2012 were excluded from
the sampling frame. Of the remaining 235 health fa-
cilities providing HIV treatment and care services to
≥400 patients, a total of 31 health facilities were sam-
pled using a probability proportional to size (PPS)
sampling criterion [19]. The PPS sampling was done
to ensure sampling of a range of ART sites that are
representative of Zimbabwe whilst taking into account
all the 10 geographical regions. The minimum
required sample size of HIV-positive clients enrolled
in ART clinics regardless of age was 1,420 assuming
that the prevalence of malnutrition among adult
PLHIV was 10.3% [12], without using a population
correction factor, and using a design effect of 2, a
95% confidence interval, a 2.5% margin of error and
assuming a response rate of 80%.
Confirmed HIV-positive individuals who were en-
rolled in HIV treatment and care at the selected health
facilities providing ART services were targeted for this
survey. Overall there were 1,527 study respondents,
however this paper focused only on the 1,242 partici-
pants aged ≥15 years and consisted of non-pregnant
women and men. This excluded 285 participants who
consisted of pregnant/lactating women and children
<15 years and were reserved for a separate paper.
Patients who had attended the health facility for their
scheduled HIV treatment and care appointment visit
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were recruited and interviewed prior to or after being
attended to by a health worker. Voluntary written
consent was sought from those aged ≥18 years old
whilst those aged 15–17 years were interviewed after
obtaining parental assent if they were in the company
of their parent or legal guardian.
HIV treatment and care services at health facility level
Once patients test HIV-positive in Zimbabwe, they
are referred to a health facility that provides HIV
treatment and care services. Patients are retested to
confirm their HIV-positive status and are immediately
registered in the pre-ART register. They are assigned
a unique ART number and an individual ART care
booklet. Adult patients (aged ≥15 years old) are also
assessed for ART eligibility currently based on having
World Health Organisation (WHO) clinical staging III
or IV or having a CD4 cell count <500 cells/mL
whilst all HIV-positive pregnant women since the end
of 2013 are started on lifelong ART under Option B+
regardless of their CD4 cell count or WHO clinical
staging. TB/HIV co-infected patients and those with
chronic Hepatitis B are also initiated regardless of
clinical or immunological status. Since the inception
of the ART programme, the ART initiation criterion
among adults has shifted from a CD4 cell count
threshold of <200 cells/mL, to <350 cells/mL from
2011 to 2013 and eventually to <500 cells/mL from
2014 onwards in tandem with WHO guidelines [20–22].
ART regimens have become simpler and more efficacious
over the years, moving from stavudine + lamivudine + ne-
virapine in the first 6 years of the ART progamme since
2004 to tenofovir + lamuvidine + nevirapine, and as of
2013, to tenofovir + lamuvidine + efavirenz which is ad-
ministered as a single, fixed-dose combination pill to be
taken once daily.
In pre-ART care, patients are provided with cotrimoxa-
zole prophylaxis (CPT). A patient is seen every 2 weeks
for the first month after initiating ART, and then monthly
for the next few months in order to assess treatment
adherence, inter-current illnesses, adverse drug events,
or immune reconstitution syndrome. If patients are
stable after the initial 6 months, they are seen 6
monthly thereafter for clinical consultations. Recom-
mended clinical indices assessed at every visit include
patient weight, WHO clinical stage, screening of co-
morbidities such as TB, and ART and CPT adherence
assessment through pill counts and self-reporting by
patients. Other than prior to ART initiation, labora-
tory indices such as complete blood count (CBC) and
CD4 counts should be done six monthly whilst serum
alanine transaminase (ALT), serum creatinine, and of
late in some regions viral load counts are conducted
every 12 months.
Data variables and data collection
A three-day training workshop on familiarizing and
pilot-testing the data collection tools and procedures
was conducted prior to data collection. Data collectors
consisted of health workers with prior experience of
enumeration in other health-related surveys. Data collec-
tion was conducted between June and July of 2014 at all
31 selected ART clinics using an interviewer-administered
questionnaire with coded responses. Questionnaires were
also translated into the 2 main local languages (Shona and
Ndebele) for respondents who were not conversant with
English.
Variables collected included:- age, sex, educational level,
rural/urban residence, history of TB treatment, the type of
food consumed in the patient’s household in the 7 days
prior to the interview and household demographics such
as number of household members, household assets and
livestock and household income. Information on clinical
characteristics such as CD4 cell count, WHO clinical
staging, ART start date, and ART adherence was obtained
from the individual patient care booklets for the inter-
viewed patients. Weight and height measurements for the
study respondents were measured and recorded at the
start of the interview.
Study definitions
The main study outcome, nutritional status was based
on body mass index (BMI) and calculated as weight in
kilograms divided by height squared (kg/m2) and catego-
rized as undernutrition (severe- < 16 kg/m2; moderate–
16.0 to16.99 kg/m2 and mild–17.0 to 18.49 kg/m2) and
over-nutrition (overweight – 25.0 to 29.9 kg/m2 and
obesity-≥30 kg/m2) [23]. The wealth index, used in the
survey and adopted from Filmer and Pritchett [24], was
based on information collected from respondents on
several items that measure household ownership of con-
sumer durables which tend to be correlated with household
wealth status, and these were used to quantify differences
in household economic status. This wealth index variable
was a continuous variable which was divided into 5 equal
quintiles which were ranked from the lowest category
(termed ‘poorest quintile’) to the highest category (termed
‘richest quintile’). Food consumption score (FCS) which is a
composite score based on dietary diversity, food frequency,
and relative nutritional importance of different food groups
was categorized as poor (0–21.4), borderline (21.5–35) and
acceptable (>35) [25].
Having a household with income below US$101.25/
person per month was categorized as having income
below the Zimbabwe poverty datum line (PDL) for
2014 [26]. Likewise having household minimum con-
sumption expenditure for food below US$31.52/per-
son per month, which is necessary to ensure that each
household member can consume a minimum food
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basket representing 2,100 cal was defined as house-
hold income below the national food poverty line
(FPL) for 2014 [26].
Statistical analysis
Patient data collected in the questionnaires were
coded and single entered by 7 data entry clerks into
EpiData (version 3.1; EpiData Association, Odense,
Denmark) and later cleaned for errors and analyzed
using Stata/SE 13.0 (Stata Corp, 2013, Stata Statistical
Software: Release 13.0, College Station, TX). Prior to
statistical analysis, data were weighted using proportional
weights, in order to account for unequal probabilities of
selection in the sampling and also to account for the com-
plex design of the survey (i.e., stratification and clustering).
Percentages and frequencies were generated for cat-
egorical variables while means (standard deviations)
or alternatively medians (inter-quartile ranges (IQR))
were calculated for continuous variables as deemed
appropriate.
Associations between the primary outcome mea-
sures (undernutrition and over-nutrition) with socio-
demographic, food security and vulnerability variables
and clinical characteristics were determined using the
Pearson’s chi-squared test or alternatively Fischer’s
Exact test. Univariate and multivariate-adjusted odds
ratios (aOR) and their respective 95% confidence intervals
(CI) were calculated to determine factors associated with
undernutrition and over-nutrition. Explanatory variables
that were included in the multi-variate logistic regression
models were those that had p-values ≤0.25 in bi-variate
analysis with the outcome measures. P-values <0.05 were
considered as statistically significant.
Results
Table 1 shows the socio-demographic characteristics of
the 1,242 HIV-positive adults who were enrolled in this
study. There were 849 (68%) females and the overall me-
dian age of all participants was 41 years (IQR, 34–49).
Slightly more study participants resided in the rural
areas (n = 699, 56%) compared to urban areas (n = 543,
44%). The majority of respondents had attained second-
ary school education (n = 662, 57%) as their highest level
of education while 467 (40%) had attained primary
school education.
Table 2 shows food security and vulnerability char-
acteristics among study respondents. Only 32 (3%) re-
spondents had a poor household food consumption
score whilst 261 (21%) had a borderline household
food consumption score. Slightly over ten percent of
respondents reported having previously received food
aid whilst 389 (31%) reported having experienced diffi-
culty in accessing food in the month preceding the
survey. Approximately nine in ten respondents had a
household income below the poverty datum line and
the food poverty line.
Clinical characteristics among HIV-positive adults en-
rolled in the study are shown in Table 3.
As shown in Table 3, the majority of respondents (n
= 1,152, 93%) were on ART and their median duration
on treatment was 3 years (IQR, 1.1–4.3). Self-reported
adherence to ART in the month preceding the survey
was high with 1,056 (93%) reporting adherence ≥95%.
Nearly a third of respondents reported a history of TB
treatment whilst 165 (13%) reported experiencing
diarrhoea in the two weeks prior to the survey.
Slightly more than half of the study respondents (56%)
were documented with an illness characterised by
WHO clinical stage 3 or 4 at the most recent visit.
Only 349 (28%) study participants had a CD4 cell
count measurement taken within six months of the
interview date, and of these patients, the median CD4
cell count was 348 cells/mL (IQR, 174–510).
Table 1 Socio-demographic characteristics among HIV-positive
adults enrolled in ART clinics in Zimbabwe
Characteristic n N % (95% CI)
Area
Urban 543 1,242 43.7 (43.4–48.4)
Rural 699 1,242 56.3 (51.6–56.6)
Sex
Male 393 1,242 31.6 (29.1–34.3)
Female 849 1,242 68.4 (65.7–70.9)
Age in Years
15–24 51 1,242 4.1 (3.1–5.4)
25–34 288 1,242 23.2 (20.9–25.6)
35–44 464 1,242 37.4 (34.7–40.1)
45–54 265 1,242 21.3 (19.1–23.7)
> =55 174 1,242 14.0 (12.2–16.1)
Median (IQR) 1,242 41 (34; 49)
Education Level
Primary 467 1,159 40.3 (37.5–43.2)
Secondary 662 1,159 57.1 (54.2–59.9)
Higher 30 1,159 2.6 (1.8–3.7)
Missing 83 1,242 6.7 -
Wealth quintile
Lowest 251 1,242 20.2 (18.1–22.5)
Second 252 1,242 20.3 (18.1–22.6)
Middle 243 1,242 19.6 (17.4–21.9)
Fourth 235 1,242 18.9 (16.8–21.2)
Highest 261 1,242 21.0 (18.8–23.4)
HIV Human Immunodeficiency virus, ART antiretroviral therapy, IQR
interquartile range
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The nutritional status according to BMI among
enrolled study patients is shown in Fig. 1. The mean
BMI for all HIV-positive patients was 23.5 kg / m2
(standard deviation 9.4). The majority (n = 776, 63.6%)
had a normal BMI, 122 (10%) had under nutrition
which was severe in 17 (1.4%), moderate in 18 (1.5%)
and mild in 87 (7.1%). There were 224 (18.4%) who
were overweight and 98 (8%) with obesity: thus over-
all 26% of all respondents were classified with over-
nutrition.
Factors associated with undernutrition
Factors associated with under-nutrition among enrolled
study participants are shown in Table 4. Females when
compared to males were less likely to have undernutri-
tion [aOR = 0.31 (95% CI, 0.20–0.47)]. Compared to 15-
24 year olds, those of older age were also less likely to
have undernutrition; 35–44 years [aOR = 0.33 (95% CI,
0.14–0.76)] and ≥45 years [aOR = 0.43 (95% CI, 0.19–
0.99)]. Those reporting difficulty in accessing food in the
month prior to the survey had a higher likelihood of un-
dernutrition [aOR = 1.67 (95%CI, 1.10–2.55)]. Having
WHO clinical stage 3 or 4 was associated with a two-
fold higher odds of having undernutrition [aOR = 2.25
(95% CI, 1.34–3.77)]. No significant differences were
noted in risk factors for undernutrition when stratified
by rural/urban residence.
Factors associated with over-nutrition
Table 5 shows factors associated with over-nutrition
among enrolled HIV-positive study participants in ART
clinics in Zimbabwe. Females when compared to males
were nearly four times more likely to have over-nutrition
[aOR = 3.86 (95% CI, 2.72–5.48)]. Over-nutrition was
also higher among those aged ≥45 years [aOR = 2.24
(95% CI, 1.01–5.04)] in comparison to those aged 15–24
Table 3 Clinical characteristics among HIV-positive adults
enrolled in ART clinics in Zimbabwe
Characteristic n N % (95% CI)
Experienced diarrhoea in the past 2 weeks
No 1,077 1,242 86.7 (84.7–88.5)
Yes 165 1,242 13.3 (11.5–15.3)
ART status
No 90 1,242 7.3 (5.9–8.8)
Yes 1,152 1,242 92.8 (91.2–94.1)
Duration on ART in years
< 1 248 1,152 21.5 (19.2–24.0)
1–2 306 1,152 26.6 (24.1–29.2)
3–4 339 1,152 29.4 (26.9–32.1)
5–6 168 1,152 14.6 (12.7–16.7)
> 6 91 1,152 7.9 (6.5–9.6)
Median (IQR) 1,152 3 (1.1–4.3)
ART adherence in the past month
< 95% 83 1,139 7.3 (5.9–9.0)
≥ 95% 1,056 1,139 92.7 (91.0–94.1)
Missing 13 1,152 1.1 -
History of TB treatment
No 894 1,238 72.2 (69.6–74.6)
Yes 344 1,238 27.8 (25.4–30.4)
Missing 4 1,242 0.3 -
Current WHO stage
I/II 464 1,045 44.4 (41.4–47.4)
III/IV 581 1,045 55.6 (52.6–58.6)
Missing 197 1,242 15.9 -
Current CD4 cell counta
≤ 50 26 349 7.5 (5.1–10.7)
51–200 75 349 21.5 (17.5–26.1)
201–350 75 349 21.5 (17.5–26.1)
351–500 78 349 22.4 (18.3–27.0)
> 500 95 349 27.2 (22.8–32.2)
Missing 893 1,242 71.9 -
Median (IQR) 349 348 (174–510)
HIV Human Immunodeficiency Virus, ART antiretroviral therapy, IQR
interquartile range, WHO World Health Organization
aCurrent CD4 cell count was taken as a CD4 cell count obtained with
6 months from date of data collection
Table 2 Food security and vulnerability characteristics among
HIV-positive adults enrolled in ART clinics in Zimbabwe
Characteristic n N % (95% CI)
Household Food consumption score
Poor (0–21.4) 32 1,242 2.6 (1.8–3.6)
Borderline (21.5–35) 261 1,242 21.0 (18.8–23.4)
Acceptable (>35) 949 1,242 76.4 (74.0–78.7)
Received Food aid
No 1,100 1,242 88.6 (86.7–90.2)
Yes 142 1,242 11.4 (9.8–13.3)
Had difficulty accessing food in the past 30 days
No 853 1,242 68.7 (66.0–71.2)
Yes 389 1,242 31.3 (28.8–34.0)
Household Income compared to PDL
above PDL 135 1,074 12.6 (10.7–14.7)
Below PDL 939 1,074 87.4 (85.3–89.3)
Missing 168 1,242 13.5 -
Household Income compared to FPL
above FPL 102 1,240 8.2 (6.8–9.9)
below FPL 1,138 1,240 91.8 (90.1–93.2)
Missing 2 1,242 0.2 -
HIV Human Immunodeficiency Virus, ART antiretroviral therapy, PDL poverty
datum line, FDL food poverty line
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years old. The odds of having over-nutrition also in-
creased with higher wealth quintile [highest versus low-
est quintile – aOR = 2.84 (95%CI, 1.66–4.86)] and with
increasing CD4 cell count of CD4 > 350 cells/mL [aOR
= 4.85 (95% CI, 1.03–22.77)].
Multivariate regression for risk factors associated with
over-nutrition was also carried out when stratified by
rural/urban residence (data are not shown). The odds of
over-nutrition increased with higher wealth quintile for
urban dwellers only [highest versus lowest quintile –
aOR = 3.39 (95%CI, 1.52–7.56)] whilst no differences
were noted for rural dwellers. For rural dwellers, difficulty
in accessing food in the past 30 days was associated with a
lower odds of over-nutrition [aOR = 0.33(95%CI, 0.15–
0.74)] whilst no differences were noted for urban dwellers.
Discussion
This is the first nationally representative study in Zimbabwe
conducted among HIV-positive patients enrolled in HIV
treatment and care settings and aimed at determining
prevalence of malnutrition and associated factors. Our
study findings show that there is a high burden of malnutri-
tion with about two in five of all HIV-positive patients
being affected. Of note, the problem of malnutrition is a
double-edged sword with both over-nutrition and undernu-
trition being prevalent in this population. Over-nutrition
affected approximately a quarter of all patients in compari-
son to under-nutrition which affected only a tenth of all
HIV-positive patients. We also observed that undernutri-
tion was more prevalent among males compared to
females, among older adolescents and young adults, among
those who encountered difficulty accessing food in the past
month and those with advanced HIV disease. We also ob-
served that over-nutrition was higher among females, in
the older age groups and also increased with higher wealth
quintile and increasing CD4 cell count.
The strengths of this study include a large sample and
the use of PPS sampling which ensured that our findings
are nationally representative of HIV-positive patients en-
rolled in HIV treatment and care settings in Zimbabwe.
The weight of study participants was measured using
standardized and calibrated weight scales whilst height
was measured using standardized height boards thus
ensuring the body mass indices for these patients were
current, accurate and comparable. A standardized ques-
tionnaire was also administered by trained data collec-
tors and this ensured that all study participants were
comparable. Study limitations may have included the
possibility of recall bias by study respondents on the
type of foods consumed in their households in the week
preceding the survey and the frequency of their con-
sumption. This may have led to incorrect calculation
and misclassification of the household food consumption
score. This study may not be representative of those
HIV-positive patients who were enrolled in HIV treat-
ment and care settings but missed their scheduled clinic
review visits because they were too sick to attend the
clinic. Whilst data were collected for pregnant and lac-
tating women and those aged <15 years old, these were
excluded from the analysis of nutritional status since
their numbers were too small to allow meaningful infer-
ences and also because body mass index is not an appro-
priate measure of nutritional status in pregnant and
lactating women. Lastly, the use of BMI may underesti-
mate the prevalence of obesity since it is reported to
have low sensitivity and can miss a proportion of adults
with excess body adiposity [27, 28].
In this study we observed that undernutrition was less
common when compared to over-nutrition among HIV-
positive adults enrolled in ART clinics in Zimbabwe.
This is in sharp contrast to other studies in the African
region where malnutrition (BMI < 18.5 kg/m2) was more
Fig. 1 Nutritional status among HIV-positive adults enrolled in ART clinics in Zimbabwe. SAM = severe acute malnutrition; MAM =moderate acute
malnutrition; HIV = Human Immunodeficiency Virus; ART = antiretroviral therapy
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common and as high as 26.3% [14] and 36% [29]. In one
meta-analysis published in 2015, malnutrition (BMI <
18.5 kg/m2) was reported as one of the leading causes of
hospital admission among HIV-positive adults in the
Africa region [30]. Weight loss which leads to severe
and moderate malnutrition is common in HIV infection
and can be caused by low dietary intake due to loss of
appetite, mouth ulcers, food insecurity and also due
to malabsorption of macronutrients and an altered me-
tabolism [31]. Men were more likely to have undernutri-
tion compared to women, and we attribute this to the
established fact that they present late for HIV treatment
and care with advanced HIV disease and low CD4 counts
in Zimbabwe [32] and other African settings [33, 34].
Lower CD4 cell counts have been found to be associated
with severe and moderate malnutrition [14, 29] and these
are also associated with increased mortality [35]. Similar
to other studies, household food insecurity which affects
the frequency of meals and dietary diversity of meals con-
sumed in a household has been commonly reported as a
predictor of poor nutritional status [36]. There were no
differences in levels of undernutrition between PLHIV in
rural and urban residences and this could be explained by
our findings that show that study participants were
generally from poor households given that the majority
had household incomes below the national poverty datum
line and food poverty line. Whilst urban dwellers may be
perceived to have better food security and subsequently
better nutritional status due to high economic activity,
high levels of food insecurity and consequently mal-
nutrition have been reported in Southern Africa and
are related to rapid urbanization resulting in informal
settlements [37].
In our sample, there were significantly higher propor-
tions of HIV-positive patients who were overweight or
obese compared with those at the other end of the scale.
Our data also shows that the prevalence of being over-
weight and obese was slightly lower among HIV-positive
women compared to women in the general population,
with this data taken from women in the 2010-11
Zimbabwe Demographic and Health Survey (ZDHS) [38].
Interestingly, the population prevalence of women who
were overweight or obese from this ZDHS (31%) was
higher than the pooled prevalence for the Sub-Saharan
Africa region at 23% [38], and this could be related to the
2011 World Bank poverty headcount ratio at US$1.90
which was 21% for Zimbabwe compared to 44% for sub-
Saharan Africa [39]. Increasing CD4 cell count was found
to be associated with being overweight and obese and this
concurs with findings from a follow-up of 17 ART cohorts
in North America with sustained viral suppression [40, 41].
With women being more likely to be overweight or obese
relative to men, this may again be related to their earlier
entry into HIV care and ART initiation with relatively
Table 4 Factors associated with under-nutrition among HIV-
positive adults enrolled in ART clinics in Zimbabwe
Characteristic n (%) OR (95% CI) aOR (95% CI)
Area
Urban 58 (11.0) reference reference
Rural 64 (9.2) 0.82 (0.56; 1.19) 0.87 (0.57; 1.32)
Sex
Male 66 (17.1) reference reference
Female 56 (6.7) 0.35 (0.24; 0.51) 0.31 (0.20; 0.47)
Age in years
15–24 10 (20.4) reference reference
25–34 29 (10.4) 0.45 (0.2; 1) 0.50 (0.21; 1.20)
35–44 37 (8.0) 0.34 (0.16; 0.74) 0.34 (0.15; 0.80)
45–54 46 (10.7) 0.47 (0.22; 1.02) 0.43 (0.19; 0.99)
Received Food aid
No 102 (9.5) reference reference
Yes 20 (14.1) 1.57 (0.94; 2.63) 1.36 (0.77; 2.39)
Had difficulty accessing food in the past 30 days
No 72 (8.6) reference reference
Yes 50 (13.0) 1.59 (1.08; 2.33) 1.67 (1.10; 2.55)
Experienced diarrhoea in the past 2 weeks
No 97 (9.2) Reference reference
Yes 25 (15.6) 1.84 (1.14; 2.96) 1.49 (0.89; 2.52)
ART status and duration in years
Pre-ART 11 (12.5) Reference reference
< 1 33 (13.5) 1.09 (0.53; 2.27) 0.75 (0.41; 1.39)
1–2 28 (9.3) 0.72 (0.34; 1.51) 0.65 (0.34; 1.21)
3–4 27 (8.1) 0.62 (0.29; 1.3) 0.74 (0.36; 1.54)
5–6 16 (9.9) 0.77 (0.34; 1.73) 0.56 (0.21; 1.45)
> 6 7 (7.7) 0.58 (0.22; 1.58) 1.26 (0.57; 2.81)
History of TB treatment
No 75 (8.5) Reference reference
Yes 47 (13.9) 1.74 (1.18; 2.56) 1.30 (0.84; 2.01)
Current WHO stage
I/II 28 (6.1) Reference reference
III/IV 72 (12.6) 2.2 (1.4; 3.47) 2.25 (1.34; 3.77)
Current CD4 cell counta
≤ 50 8 (30.8) reference reference
51–200 10 (13.5) 0.35 (0.12; 1.02) 0.47 (0.14; 1.51)
201–350 8 (11.0) 0.28 (0.09; 0.84) 0.43 (0.13; 1.45)
≥ 350 18 (10.4) 0.26 (0.10; 0.69) 0.53 (0.18; 1.56)
OR odds ratio, aOR multivariate-adjusted odds ratio, CI confidence interval, HIV
Human Immunodeficiency Virus, ART antiretroviral therapy, TB Tuberculosis,
WHO World Health Organization
aCurrent CD4 cell count was taken as a CD4 cell count obtained with
6 months from date of data collection
NB: All odds ratios and 95% confidence intervals in bold font are statistically
significant with p-values <0.05
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higher CD4 cell counts compared to men [40, 41]. In many
African settings including Zimbabwe, women have better
access than men to HIV testing and treatment services
through integration of HIV testing services in antenatal care
settings [42], which act as an entry point into prevention-
of-mother-to- child HIV transmission (PMTCT) services.
Given that the majority of HIV-positive individuals enrolled
in this study were on ART, there may also be a high preva-
lence of HIV-related lipodystrophy which has been re-
ported, in one systematic review study, to develop within
the first six months of therapy particularly with the use of
stavudine [43]. Lipodystropy can predispose HIV-positive
individuals to cardiovascular disease [44], and hence the
need to evaluate its prevalence, pathogenesis and prognosis
in order to inform clinical management given the rapid na-
tional scale-up of ART and the subsequent longer survival
as HIV-related mortality continues to decline. However, the
use of stavudine based antiretroviral regimens has been
phased out since 2013 due to these adverse events.
In addition, metabolic complications such as dyslipid-
emia, insulin resistance, and diabetes mellitus are also
common among obese patients with well-controlled HIV-
infection who are on long-term ART. These complications
are also associated with increased risk of cardiovascular
disease. Metabolic complications probably develop due to
traditional risk factors such as obesity or genetic predis-
position and HIV-specific and ART-specific contributions
including chronic inflammation and immune activation
[45]. Study participants who were of a higher wealth index
were more likely to be overweight and obese but this trend
was observed only among the urban participants. Unlike
rural dwellers, where food insecurity is an issue, this trend
is likely to be due to urban dwellers having better food
security, having access to more refined and unhealthy food
diets and also having more sedentary lifestyles [46]. Other
studies have also found people of higher socioeconomic
and wealth status [38] to have a higher prevalence of
obesity and they are more likely to develop or have hyper-
tension and diabetes [47].
Table 5 Factors associated with over-nutrition among HIV-
infected adults enrolled in ART clinics in Zimbabwe
Characteristic n (%) OR (95% CI) aOR (95% CI)
Area
Urban 163 (31.0) reference reference
Rural 159 (22.9) 0.66 (0.51–0.85) 0.9 (0.66–1.25)
Sex
Male 51 (13.2) reference reference
Female 271 (32.5) 3.16 (2.28–4.39) 3.86 (2.72–5.48)
Age in years
15–24 9 (18.4) reference reference
25–34 70 (25.1) 1.49 (0.69–3.22) 1.48 (0.65–3.36)
35–44 118 (25.6) 1.53 (0.72–3.25) 1.60 (0.72–3.56)
≥ 45 125 (29.0) 1.82 (0.86–3.85) 2.24 (1.01–5.04)
Wealth quintile
Lowest 36 (14.5) reference reference
Second 65 (25.9) 2.06 (1.31–3.23) 2.07 (1.29–3.33)
Middle 60 (24.9) 1.95 (1.23–3.09) 1.94 (1.19–3.17)
Fourth 79 (34.5) 3.10 (1.99–4.85) 3.15 (1.91–5.18)
Highest 82 (32.7) 2.86 (1.84–4.44) 2.84 (1.66–4.86)
Household Food consumption score









Acceptable (>35) 260 (27.9) 1.22 (0.51–2.88) 1.06 (0.43–2.64)
Had difficulty accessing food in the past 30 days
No 229 (27.4) reference reference
Yes 93 (24.2) 0.85 (0.64–1.12) 0.85 (0.62–1.16)
Household Income compared to PDL
above PDL 47 (36.2) reference reference
Below PDL 238 (25.7) 0.61 (0.41–0.9) 0.84 (0.52–1.35)
Household Income compared to FPL
above FPL 40 (40.4) reference reference
below FPL 282 (25.2) 0.5 (0.32–0.76) 0.52 (0.31–0.87)
Duration on ART in years
Pre-ART 20 (22.7) reference reference
< 1 57 (23.4) 1.13 (0.76–1.67) 0.92 (0.59–1.45)
1–2 77 (25.6) 1.25 (0.85–1.83) 1.04 (0.67–1.63)
3–4 92 (27.5) 1.26 (0.80–1.99) 0.91 (0.54–1.54)
5–6 45 (27.8) 1.70 (1.00–2.87) 1.12 (0.61–2.04)
> 6 31 (34.1) 0.96 (0.54–1.72) 0.85 (0.45–1.59)
Current WHO stage
I/II 132 (29.0) reference reference
III/IV 143 (25.0) 0.82 (0.62–1.08) 0.89 (0.65–1.20)
Table 5 Factors associated with over-nutrition among HIV-
infected adults enrolled in ART clinics in Zimbabwe (Continued)
Current CD4 cell counta
≤ 50 2 (7.7) reference reference
51–200 10 (13.5) 1.87 (0.38–9.19) 1.66 (0.32–8.62)
201–350 21 (28.8) 4.85 (1.05–22.36) 4.51 (0.92–22.15)
> 350 58 (33.5) 6.05 (1.38–26.5) 4.85 (1.03–22.77)
OR odds ratio, aOR multivariate-adjusted odds ratio, CI confidence interval, HIV
Human Immunodeficiency Virus, ART antiretroviral therapy, PDL poverty datum
line, FPL food poverty line, WHO World Health Organization
aCurrent CD4 cell count was taken as a CD4 cell count obtained with
6 months from date of data collection
NB: All odds ratios and 95% confidence intervals in bold font are statistically
significant with p-values <0.05
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This study has a number of implications. First, there is a
double burden of undernutrition and over-nutrition
amongst the country’s population of HIV-positive patients
enrolled in ART clinics. It is therefore important that
health workers routinely assess and document weight and
height measurements in individual health facility records
to enable BMI monitoring as a proxy measure of nutri-
tional status. A previous nationally representative record
review of ART treatment outcomes among HIV-positive
patients enrolled in ART clinics in Zimbabwe showed that
approximately a quarter of all patients did not have re-
corded weight at ART initiation and this must change and
improve [40]. Low baseline weight at ART initiation has
been shown to increase the risk of ART attrition from care
and mortality [40, 48] and given its association with late
presentation with advanced HIV, this points towards a
need to encourage early seeking of HIV testing services
and subsequent ART initiation. Currently, the national
ART programme is shifting towards an HIV ‘treat-all’
approach which promotes earlier ART initiation with
promising improved treatment outcomes.
Second, the addition of micronutrient supplements to
ART may provide increased nutritional recovery among
HIV-positive patients with undernutrition [49, 50] and also
more importantly improve adherence to ART among food-
insecure adults as has been shown in Zambia [51] though
no significant gains were observed with respect to weight
and CD4 cell count response. However, despite improved
health and ART adherence, perceptions among food-
insecure HIV-positive adults participating in one Kenyan
food supplementation program highlighted the inevitability
of sharing food disbursements with people outside their
families thus depleting the food available for them [52].
Any adoption of food supplementation programmes in
ART clinics will therefore need to take this into consider-
ation so as to ensure that the targeted malnourished HIV-
positive patients benefit from these interventions.
Third, with obesity becoming prevalent in the HIV
population on ART, HIV may change from being a
highly fatal infectious disease into a chronic manageable
disease that is associated with an elevated risk of
cardiovascular-related conditions such as diabetes melli-
tus and hypertension. This calls for an urgent need to
integrate the screening and management of hypertension
and diabetes mellitus into HIV clinics [53], and particu-
larly among patients who are overweight and obese.
Conclusion
In conclusion, we have found that being overweight or
obese is more prevalent than being underweight in HIV-
positive patients enrolled in HIV treatment and care
settings and on ART in Zimbabwe, and this is more
common in females, in those of older age and in those
with increasing wealth index. Given that over-nutrition
predisposes patients to cardiovascular-related conditions,
there is an urgent need to integrate into HIV treatment
and care services the screening of hypertension and
diabetes mellitus in order to enable these conditions to
be identified and appropriately managed to prevent car-
diovascular complications.
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